News | Artificial Intelligence | November 13, 2018

Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018

Deep learning algorithms designed for faster scans and reduced radiation dose

Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018

November 13, 2018 — At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical will showcase SubtlePET, its artificial intelligence (AI)-powered technology. SubtlePET allows hospitals and imaging centers to deliver a faster and safer patient scanning experience, while enhancing exam throughput and provider profitability. The software is currently under U.S. Food and Drug Administration (FDA) 510k review and in pilot use in multiple university hospitals and imaging centers in the U.S. and abroad.

SubtlePET leverages AI to allow hospitals and imaging centers to accelerate positron emission tomography (PET) scan times four-fold or reduce PET radiation dose by up to 75 percent, according to the company.

A second product pending FDA submission is SubtleMRI, which allows imaging centers to significantly accelerate magnetic resonance imaging (MRI) scans. Subtle Medical’s focus on image acquisition and workflow differentiates it from most AI imaging companies, which are focusing on post-processing and computer-aided diagnosis.

Subtle Medical technology utilizes deep learning algorithms that integrate seamlessly with any original equipment manufacturer (OEM) PET and MRI scanners to enhance images during acquisition without any interruption or alteration in the imaging specialists’ workflow.  The result is shorter scan duration or less exposure to radiation, which is particularly beneficial for children and those undergoing repeat PET exams.

In March 2018, Subtle Medical received the NVIDIA Inception Award Top Healthcare+AI Startup Globally from among over 3,000 AI contenders. The company was also selected as the first AI+healthcare startup for Bessemer Venture Partner’s Deep Health Seed Program.

Subtle Medical’s core technology was developed at Stanford University.  The company has licensed multiple patented technologies invented by the founders at Stanford as well as medical imaging datasets acquired during clinical research at Stanford radiology labs.

At RSNA 2018, Subtle Medical’s co-founders will be participating in research and industry presentations along with other academic collaborators from Stanford. Presentations include:

Lunch and Learn: Thinking Faster, Safer, & Smarter: How You Can Use AI to improve MR and PET Imaging Efficiency, Patient Satisfaction, and Safety

Greg Zaharchuk, M.D., Ph.D. |Chris Hess, M.D., Ph.D. | Paul Chang, MS, M.D. | Michael Brant-Zawadzki, M.D., FACR

Wednesday 12:30-1:30 PM | LL33  

 

Machine Learning Theater: AI Improves Imaging Workflow for MR and PET Exams: Faster, Safer, and Smarter

Greg Zaharchuk, M.D., Ph.D. |Enhao Gong, Ph.D.

Monday 12:00-12:20 PM | ML23

 

Evaluation of Deep-Learning-Based Technology for Reducing Gadolinium Dosage in Contrast-Enhanced MRI Exams

Enhao Gong, Ph.D. | Jonathan Tamir, BSC | John Pauly | Max Wintermark, M.D. | Greg Zaharchuk, M.D., Ph.D.

Physics (MR: New Techniques, Systems, Evaluation)

Monday 10:30-12:00 PM | SSC12 | Presentation 9 of 9

 

Does 18F-FDG Dose Reduction for PET/MRI Affect Treatment Response Assessment of Lymphomas and Sarcomas?

Ketan Yerneni |Anne Muehe, M.D. | Praveen Gulaka, Ph.D. | K. Elizabeth Hawk, M.D., Ph.D. | Ashok Joseph Theruvath, M.D. | Heike Daldrup-Link, M.D.

Monday 12:45-1:15 PM | PD218-SD-MOB4

 

Stroke Outcome Prediction from Meta Information Available at Patient Admission

Yuan Xie | Bin Jiang | Enhao Gong, Ph.D. | Ying N. Li | Guangming Zhu | Bo Zhou | Patrik Michel | Max Wintermark, M.D. | Greg Zaharchuk, M.D., Ph.D.

Neuroradiology Series: Stroke

Wednesday 8:30-12:00 PM | RC505 | Presentation 10 of 12

 

Deep Learning Segmentation for Detection of Brain Metastases in the Small Data Regime

Daniel L. Rubin, M.D., MS | Greg Zaharchuk, M.D., Ph.D. | Michael Iv, M.D. | Rhea Singh

Neuroradiology (Dots and Dashes: Image Analysis in Neuroradiology)

Thursday 10:30-12:00 PM | SSQ15 | Presentation 8 of 9

For more information: www.subtlemedical.com

 

Related Content

Mednax, a leading health solutions partner specializing in prenatal, neonatal, pediatric and radiology services, announced a number of steps it is taking as part of its aggressive transformational activity to position the company for long-term, sustainable growth
News | Radiology Business | June 05, 2020
June 5, 2020 — Mednax, a leading health solutions partner specializing in prenatal, neonatal, pediatric and radiology
Chief among the myriad practical updates to minimize risks for patients and imaging personnel alike is a tiered approach for delaying both outpatient and inpatient cross-sectional interventional procedures

For procedural delays that will not adversely affect patient outcome, Fananapazir and colleagues proposed the following tiered approach for both outpatient and inpatient scenarios: urgent procedures, procedures that should be performed within 2 weeks, procedures that should be performed within 2 months, and procedures that can safely be delayed 2 or 6 months. Courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — An...
Early diagnosis of cancer is one of the highest-priority problem for the healthcare system, because it is critical for overall treatment success and saving patients' lives. Diffusion-weighted magnetic resonance imaging (DWI) may be used to detect a malignancy in various tissues and organs. It has the advantage of providing insight into the diffusion of water molecules in body tissues without exposing patients to radiation.

DWI of the phantom with polyvinylpyrrolidone (PVP) solutions (b value 500 s/mm2). Image courtesy of Kristina Sergunova et al.

News | Magnetic Resonance Imaging (MRI) | June 02, 2020
June 2, 2020 — Early diagnosis of cancer is one of the highest-priority problem for the healthcare system, because it
Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels. An American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. #COVID19 #SARScov2
News | Nuclear Imaging | June 01, 2020
June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to a
The FDA has approved Lilly’s TAUVID (flortaucipir F 18 injection), a radioactive diagnostic agent, for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease

Getty Images

News | Contrast Media | June 01, 2020
June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for...
MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

 

News | Radiation Therapy | June 01, 2020
June 1, 2020 — RefleXion Medical, a therape
AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020
May 29, 2020 — GE Healthcare announced U.S.
Largest case series (n=30) to date yields high frequency (77%) of negative chest CT findings among pediatric patients (10 months-18 years) with COVID-19, while also suggesting common findings in subset of children with positive CT findings

A and B, Unenhanced chest CT scans show minimal GGOs (right lower and left upper lobes) (arrows) and no consolidation. Only two lobes were affected, and CT findings were assigned CT severity score of 2. Image courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — An investigation published open-access in the ...